BCM
THRD

BML Capital Management’s Third Harmonic Bio THRD Stock Holding History

BML Capital Management’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,824,417
Closed – – 23
2025
Q3 		$0 Hold
3,824,417
– – ﹤0.01% 25
2025
Q2 		$20.8M Hold
3,824,417
– – 15.71% 2
2025
Q1 		$13.3M Buy
+3,824,417
New +$18.5M 10.74% 3

Other funds holding THRD

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BML Capital Management's THRD Position: Q4 2025 in Review

BML Capital Management sold out of Third Harmonic Bio (THRD) in Q4 2025, closing a stake of 3,824,417 shares.

BML Capital Management first reported a position in THRD in Q1 2025 and held it in 3 quarters. The position peaked at $20.8M in Q2 2025. 4 funds tracked by Wall St. Rank hold THRD as of Q4 2025.

  • BML Capital Management reported no remaining Third Harmonic Bio position as of Q4 2025 after selling out during the quarter.
  • BML Capital Management sold 3,824,417 Third Harmonic Bio shares in Q4 2025.
  • BML Capital Management first reported a position in Third Harmonic Bio in Q1 2025 and held it in 3 quarters.
  • BML Capital Management's Third Harmonic Bio position peaked at $20.8M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2025.

Based on BML Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.